Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

BIOBANK Renal Transplantation University Hospitals Leuven

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by Universitaire Ziekenhuizen Leuven
Sponsor:
Information provided by (Responsible Party):
Prof Dr Maarten Naesens, Universitaire Ziekenhuizen Leuven
ClinicalTrials.gov Identifier:
NCT01331668
First received: April 6, 2011
Last updated: March 25, 2014
Last verified: March 2014

April 6, 2011
March 25, 2014
March 2004
December 2099   (final data collection date for primary outcome measure)
Renal allograft survival [ Time Frame: 50 years after transplantation ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT01331668 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
BIOBANK Renal Transplantation University Hospitals Leuven
Biobank Renal Transplantation University Hospitals Leuven

This study aims to maintain a prospective biobank of human samples obtained from donors and recipients of renal allografts, including biopsy tissue, peripheral blood samples and urine samples.

Clinical data and bio-specimens are prospectively collected and stored for undefined future translational research projects.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

Biopsy material (tissue, RNA, DNA) Peripheral blood samples (serum, plasma, RNA, DNA) Urine samples

Probability Sample

All donors and recipients of a kidney transplant at the University Hospitals Leuven

Kidney Failure
Not Provided
renal allograft donors and recipients
All de novo renal allograft recipients transplanted at the University Hospitals Leuven

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
5000
December 2099
December 2099   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • renal transplant recipients/donors

Exclusion Criteria:

  • none
Both
Not Provided
No
Contact: Maarten Naesens, MD, PhD 32 16344580 maarten.naesens@uzleuven.be
Belgium
 
NCT01331668
TRA-UZL-BIOBANK-001
No
Prof Dr Maarten Naesens, Universitaire Ziekenhuizen Leuven
Universitaire Ziekenhuizen Leuven
Not Provided
Principal Investigator: Maarten Naesens, MD, PhD University Hospitals Leuven
Universitaire Ziekenhuizen Leuven
March 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP